EBAC | European Biotech Acquisition Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	10.55 - 11.69
52 Week Range	9.28 - 14.10
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	77,641
Average Volume	127,598
Shares Outstanding	16,398,598
Market Cap	183,500,312
Sector	Financial Services
Industry	Shell Companies
IPO Date	2021-05-11

Valuation
Profitability
Growth
Health
P/E Ratio	559.50
Forward P/E Ratio	N/A
EPS	0.02
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	0
Country	Netherlands
Website	EBAC

European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.

EBAC's peers: LION

*Chart delayed

Analyzing fundamentals for EBAC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see EBAC Fundamentals page.

Watching at EBAC technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on EBAC Technicals page.